Medpace Holdings, Inc.· MEDP

Why Medpace (MEDP) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

American Capital Management Inc. Invests $111.33 Million in Medpace Holdings, Inc. $MEDP

American Capital Management Inc. bought a new stake in shares of Medpace Holdings, Inc. (NASDAQ: MEDP) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 210,217 shares of the company's stock, valued at approximately $111,329,000. Medpace makes up about 5.0%

Bank of New York Mellon Corp Takes Position in Medpace Holdings, Inc. $MEDP

Bank of New York Mellon Corp bought a new stake in Medpace Holdings, Inc. (NASDAQ: MEDP) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 146,588 shares of the company's stock, valued at approximately $77,632,000. Bank of

What Investors Should Know About Medpace CEO Troendle Selling $10 Million in Stock

The CEO sold 15,978 shares at a weighted-average price of $623.93 over two trading days ending Aug. 24, 2026. The transaction involved shares equal to 3% of Troendle's direct equity holdings and 0.3% of his total combined stake.

Medpace Stock Hovers Near Entry, Offers Second Chance After July Spike

Medpace stock is back below a buy point of 628.92. The medical research contractor delivered an earnings beat for its second quarter.

Medpace price target raised to $692 from $484 at RBC Capital

Medpace price target raised to $600 from $450 at Barclays

Medpace downgraded to Neutral from Outperform at Baird

Jefferies Downgrades Medpace (MEDP) to Hold

Medpace price target lowered to $484 from $522 at RBC Capital